The Syneos Health Podcast

Episode 031: Real World Evidence in Europe

March 20, 2019 Jeffrey Stewart / Alastair MacDonald
The Syneos Health Podcast
Episode 031: Real World Evidence in Europe
Show Notes

According to the Syneos Health 2019 Health Trend Ten, perhaps the biggest shift for 2019 and beyond is global focus on understanding what product differentiation looks like in real-world environments.  In Europe in particular, countries are implementing more stringent measures that will impact how value is assigned in the future – and real world evidence (RWE) will play a key role.

Alastair MacDonald, Senior Vice President, Real World and Late Phase at Syneos Health, discusses the complex landscape in Europe, why “real world” and “late phase” are no longer synonymous, the four key stakeholders driving the need for RWE, and more.

For more content related to real world evidence, check out our interview with David Thompson in Episode 001: The Real World Evidence Revolution, our Syneos Short in Episode 020: 21st Century Cures and our recent white paper on determining Which Real-World Research Design is Best.

Do you like what you’re hearing?  Please be sure to subscribe, rate and review us!